CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,079,000 | +0.8% | 17,561 | +0.5% | 0.00% | 0.0% |
Q4 2020 | $2,063,000 | -63.4% | 17,470 | -65.6% | 0.00% | -50.0% |
Q3 2020 | $5,639,000 | +12.2% | 50,740 | +3.1% | 0.00% | 0.0% |
Q2 2020 | $5,027,000 | +27.2% | 49,198 | +34.3% | 0.00% | 0.0% |
Q1 2020 | $3,953,000 | -19.4% | 36,621 | -13.1% | 0.00% | 0.0% |
Q4 2019 | $4,905,000 | +12.9% | 42,143 | +11.1% | 0.00% | +100.0% |
Q3 2019 | $4,344,000 | +6.5% | 37,947 | -11.3% | 0.00% | 0.0% |
Q2 2019 | $4,078,000 | +4.6% | 42,789 | +0.1% | 0.00% | 0.0% |
Q1 2019 | $3,899,000 | +14.3% | 42,727 | -4.9% | 0.00% | 0.0% |
Q4 2018 | $3,410,000 | -9.7% | 44,923 | -4.9% | 0.00% | 0.0% |
Q3 2018 | $3,778,000 | -25.0% | 47,228 | -6.9% | 0.00% | -50.0% |
Q2 2018 | $5,037,000 | -76.7% | 50,712 | -81.0% | 0.00% | -75.0% |
Q1 2018 | $21,643,000 | -77.2% | 267,201 | -77.8% | 0.01% | -76.5% |
Q4 2017 | $94,853,000 | -23.3% | 1,204,179 | -10.2% | 0.03% | -26.1% |
Q3 2017 | $123,694,000 | – | 1,340,556 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Maso Capital Partners Ltd | 143,300 | $11,464,000 | 11.16% |
Hillhouse Capital Management | 2,751,200 | $220,096,000 | 5.88% |
York Capital Management Global Advisors, LLC | 1,167,643 | $93,411,000 | 2.95% |
Kite Lake Capital Management (UK) LLP | 152,836 | $12,227,000 | 2.53% |
RUDMAN ERROL M | 80,000 | $6,400,000 | 2.39% |
Dalton Investments, Inc. | 54,551 | $4,364,000 | 2.04% |
Greenwoods Asset Management Ltd | 245,000 | $19,600,000 | 1.91% |
Point72 Hong Kong Ltd | 47,296 | $3,784,000 | 1.29% |
Temasek Holdings (Private) Ltd | 990,000 | $79,200,000 | 0.46% |
Kassirer Asset Management Corp | 6,000 | $480,000 | 0.32% |